Wendell David Associates’s Gilead Sciences GILD Stock Holding History

Wendell David Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Hold	13,440	–	–	0.18%	72
2026 Q1	$1.87M	Hold	13,440	–	–	0.2%	75
2025 Q4	$1.65M	Hold	13,440	–	–	0.17%	74
2025 Q3	$1.49M	Hold	13,440	–	–	0.15%	75
2025 Q2	$1.49M	Hold	13,440	–	–	0.15%	76
2025 Q1	$1.51M	Sell	13,440 -200	-1%	-$20.6K	0.15%	75
2024 Q4	$1.26M	Hold	13,640	–	–	0.12%	84
2024 Q3	$1.14M	Sell	13,640 -820	-6%	-$62.6K	0.11%	86
2024 Q2	$992K	Hold	14,460	–	–	0.1%	84
2024 Q1	$1.06M	Hold	14,460	–	–	0.11%	86
2023 Q4	$1.17M	Sell	14,460 -125	-0.9%	-$9.73K	0.13%	82
2023 Q3	$1.09M	Buy	14,585 +500	+4%	+$38.5K	0.13%	82
2023 Q2	$1.09M	Sell	14,085 -50	-0.4%	-$3.99K	0.12%	82
2023 Q1	$1.17M	Hold	14,135	–	–	0.14%	82
2022 Q4	$1.21M	Hold	14,135	–	–	0.15%	81
2022 Q3	$872K	Sell	14,135 -100	-0.7%	-$6.31K	0.12%	91
2022 Q2	$880K	Sell	14,235 -750	-5%	-$46.4K	0.11%	93
2022 Q1	$891K	Hold	14,985	–	–	0.1%	93
2021 Q4	$1.09M	Hold	14,985	–	–	0.11%	86
2021 Q3	$1.05M	Hold	14,985	–	–	0.12%	87
2021 Q2	$1.03M	Sell	14,985 -350	-2%	-$23.4K	0.12%	88
2021 Q1	$991K	Sell	15,335 -700	-4%	-$45.1K	0.12%	88
2020 Q4	$934K	Sell	16,035 -50	-0.3%	-$3.02K	0.11%	88
2020 Q3	$1.02M	Hold	16,085	–	–	0.14%	86
2020 Q2	$1.24M	Hold	16,085	–	–	0.18%	79
2020 Q1	$1.2M	Sell	16,085 -125	-0.8%	-$8.64K	0.2%	77
2019 Q4	$1.05M	Sell	16,210 -3,500	-18%	-$228K	0.15%	87
2019 Q3	$1.25M	Sell	19,710 -350	-2%	-$22.9K	0.18%	84
2019 Q2	$1.35M	Sell	20,060 -1,124	-5%	-$73.9K	0.2%	83
2019 Q1	$1.38M	Sell	21,184 -917	-4%	-$60.9K	0.21%	84
2018 Q4	$1.38M	Sell	22,101 -1,825	-8%	-$128K	0.25%	80
2018 Q3	$1.85M	Sell	23,926 -4,830	-17%	-$365K	0.29%	76
2018 Q2	$2.04M	Sell	28,756 -3,062	-10%	-$216K	0.35%	73
2018 Q1	$2.4M	Sell	31,818 -3,350	-10%	-$266K	0.43%	68
2017 Q4	$2.52M	Sell	35,168 -3,225	-8%	-$245K	0.43%	65
2017 Q3	$3.11M	Sell	38,393 -3,515	-8%	-$269K	0.55%	45
2017 Q2	$2.97M	Sell	41,908 -325	-0.8%	-$21.6K	0.56%	44
2017 Q1	$2.87M	Sell	42,233 -3,110	-7%	-$219K	0.55%	49
2016 Q4	$3.25M	Sell	45,343 -13,225	-23%	-$983K	0.64%	43
2016 Q3	$4.63M	Buy	58,568 +510	+0.9%	+$41.4K	0.91%	32
2016 Q2	$4.82M	Sell	58,058 -405	-0.7%	-$35.9K	0.95%	32
2016 Q1	$5.38M	Buy	58,463 +1,925	+3%	+$174K	1.04%	30
2015 Q4	$5.71M	Buy	56,538 +5,720	+11%	+$595K	1.13%	28
2015 Q3	$4.98M	Buy	50,818 +2,748	+6%	+$305K	1.02%	30
2015 Q2	$5.62M	Buy	48,070 +2,235	+5%	+$244K	1.09%	32
2015 Q1	$4.49M	Buy	45,835 +11,140	+32%	+$1.13M	0.86%	37
2014 Q4	$3.26M	Buy	34,695 +4,805	+16%	+$497K	0.64%	43
2014 Q3	$3.17M	Buy	29,890 +4,210	+16%	+$412K	0.66%	44
2014 Q2	$2.13M	Sell	25,680 -1,200	-4%	-$93.4K	0.45%	56
2014 Q1	$1.91M	Sell	26,880 -200	-0.7%	-$15.7K	0.41%	60
2013 Q4	$2.03M	Sell	27,080 -420	-2%	-$29.2K	0.45%	55
2013 Q3	$1.73M	Sell	27,500 -50	-0.2%	-$2.99K	0.42%	60
2013 Q2	$1.41M	Buy	+27,550	New	+$1.44M	0.35%	64

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wendell David Associates's GILD Position: Q2 2026 in Review

Wendell David Associates held its Gilead Sciences (GILD) position steady in Q2 2026 at 13,440 shares worth $1.7M. The position accounts for 0.18% of the portfolio, ranked #72.

Wendell David Associates first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.71M in Q4 2015. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Wendell David Associates held 13,440 shares of Gilead Sciences worth $1.7M as of Q2 2026.
Wendell David Associates left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.18% of Wendell David Associates's portfolio in Q2 2026, its #72 holding.
Wendell David Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Wendell David Associates's Gilead Sciences position peaked at $5.71M in Q4 2015.
837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.